<DOC>
	<DOCNO>NCT01135732</DOCNO>
	<brief_summary>PROTOCOL Introduction : The introduction endoscopic retrograde cholangio-pancreatography ( ERCP ) endoscopic sphincterotomy ( ES ) 1974 dramatically change treatment biliary pancreatic disease . ES permit transection Oddi 's sphincter , allow endoscopist remove stone place stent . The main indication ERCP : 1 . Removal common bile duct stone 2 . Dilation benign biliary duct strictures 3 . Stent placement patient malignancy 4 . Acute biliary pancreatitis 5 . Removal stone dilation strictures main pancreatic duct patient chronic pancreatitis 6 . Treatment biliary fistula surgical operation . Complications ES describe early ( within one month ES ) late . Early complication approximately 10 % incidence include : 1.acute pancreatitis ( 5,4 % ) 2.bleeding ( 2 % ) 3.acute cholangitis ( 1 % ) 4.acute cholecystitis ( 0,5 % ) 5 . Perforation others ( 1,1 % ) . Late complication mainly recurrence choledocholithiasis ( 2,5 % ) , narrow previous ES recurrent acute cholangitis . Furthermore , debate literature late development cholangiocarcinoma . Carcinogenesis surgical sphincteroplasty biliary-enteric anastomosis describe . Previous study show late development cholangiocarcinoma transduodenal sphincteroplasty biliary-enteric anastomosis benign disease . The incidence 7 % twenty-year follow , general population approximately 1/ 100.000 . In addition , Tocchi et al show rate cholangiocarcinoma transduodenal sphincteroplasty choledochoduodenal anastomosis 5-7 % choledochi-enteric anastomosis approximately 1,9 % . It seem ablation sphincter function cause prolonged pancreatobiliary duodenobiliary reflux . Proteolytic pancreatic enzyme activate bacterial intestinal flora colonize biliary epithelium , cause recurrent inflammation . Chronic inflammatory irritation may lead hyperplasia , dysplasia atypia epithelium , ultimately induce carcinogenesis . Eleftheriadis et al , study change biliary epithelium patient underwent choledochi-duodenal anastomosis benign disease , hyperplasia biliary epithelium demonstrate . The result atypia biliary epithelium report Kurumado et al , mice model choledochi-duodenal anastomosis . Anomalous pancreatobiliary junction choledochal cyst produce histologic alteration biliary epithelium . These fact raise great amount concern late development cancer ES . Bergman et al small trial argues ES , function biliary sphincter permanently lose . On hand , Sugiyama et al demonstrated reduction pancreatobiliary reflux 1 year ES . In addition , large population-based study show causal association ES cholangiocarcinoma , enough limitation study design . In conclusion , long term cytologic change biliary epithelium ES benign disease well know . During ERCP , brush cytology perform evaluate bile duct stricture . The use endoscopic brushing ES report complication . Objective : To evaluate cytologic alteration biliary epithelium previous endoscopic sphincterotomy benign disease .</brief_summary>
	<brief_title>Cytological Evaluation Biliary Epithelium After Endoscopic Sphincterotomy</brief_title>
	<detailed_description>Informed consent obtain patient . ERCP conduct Endoscopic Unit Aretaieion University Hospital Tzaneio General Hospital , Athens , Greece . Pethidine , midazolam propofol use patient sedation . ERCP conduct use side view endoscope . After catheterization common bile duct previous sphincterotomy , cellular material obtain use endoscopic brush bile duct . With way , brush cytology perform control group perform ES . Material obtain patient smear five glass slide . Four slide fix ethanol solution 95 % fifth air dry . The brush fix suitable liquid perform liquid phase cytology . Immunocytology immunofluorescence p-53 antibody perform sample hyperplasia , dysplasia atypia . The cytology department Tzaneio Hospital conduct examination evaluation sample . Samples base morphological characteristic classify five category : a. inadequate sample ( small cell number , presence blood , inadequate fixation ) b. negative malignancy ( adequate cell number benign morphologic characteristic ) c. reactive without atypia ( cell reactive/proliferative inflammatory characteristic . Malignancy rare exclude ) d. suspicious malignancy e. positive malignancy [ 21,22 ] . Examination evaluation specimens do two specialized cytologist , separately , order achieve objective result .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<criteria>inclusion criterion age &gt; 18 perform endoscopic sphincterotomy benign disease cholelithiasis biliary colic choledocholithiasis cholangitis biliary pancreatitis exclusion criterion biliary stricture malignancy kind</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>late development cholangiocarcinoma</keyword>
</DOC>